Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: DISEASE-FREE SURVIVAL - , . Treffer: 305

2020

Schwaab, J; Naumann, N; Luebke, J; Jawhar, M; Somervaille, TCP; Williams, MS; Frewin, R; Jost, PJ; Lichtenegger, FS; La Rosée, P; Storch, N; Haferlach, T; Horny, HP; Fabarius, A; Haferlach, C; Burchert, A; Hofmann, WK; Cross, NCP; Hochhaus, A; Reiter, A; Metzgeroth, G Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol. 2020; 95(7):824-833 Doi: 10.1002/ajh.25825 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141 Doi: 10.1186/s12885-018-4020-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gandhi, L; Rodríguez-Abreu, D; Gadgeel, S; Esteban, E; Felip, E; De Angelis, F; Domine, M; Clingan, P; Hochmair, MJ; Powell, SF; Cheng, SY; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Hui, R; Garon, EB; Boyer, M; Rubio-Viqueira, B; Novello, S; Kurata, T; Gray, JE; Vida, J; Wei, Z; Yang, J; Raftopoulos, H; Pietanza, MC; Garassino, MC; KEYNOTE-189 Investigators Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018; 378(22): 2078-2092. Doi: 10.1056/NEJMoa1801005
Web of Science PubMed FullText FullText_MUG

 

Juntermanns, B; Kaiser, GM; Orth, L; Reis, H; Jaradat, D; Sydor, S; Buechter, M; Kasper, S; Mathé, Z; Sotiropoulos, GC; Baba, HA; Canbay, A; Paul, A; Fingas, CD Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinoma.
Eur J Med Res. 2018; 23(1):29-29 Doi: 10.1186/s40001-018-0329-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinaldetti, S; Pfirrmann, M; Manz, K; Guilhot, J; Dietz, C; Panagiotidis, P; Spiess, B; Seifarth, W; Fabarius, A; Müller, M; Pagoni, M; Dimou, M; Dengler, J; Waller, CF; Brümmendorf, TH; Herbst, R; Burchert, A; Janβen, C; Goebeler, ME; Jost, PJ; Hanzel, S; Schafhausen, P; Prange-Krex, G; Illmer, T; Janzen, V; Klausmann, M; Eckert, R; Büschel, G; Kiani, A; Hofmann, WK; Mahon, FX; Saussele, S Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
Clin Lymphoma Myeloma Leuk. 2018; 18(4):266-271 Doi: 10.1016/j.clml.2018.02.004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Smith, MR; Saad, F; Chowdhury, S; Oudard, S; Hadaschik, BA; Graff, JN; Olmos, D; Mainwaring, PN; Lee, JY; Uemura, H; Lopez-Gitlitz, A; Trudel, GC; Espina, BM; Shu, Y; Park, YC; Rackoff, WR; Yu, MK; Small, EJ; SPARTAN Investigators Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med. 2018; 378(15): 1408-1418. Doi: 10.1056/NEJMoa1715546 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tsibulak, I; Wieser, V; Degasper, C; Shivalingaiah, G; Wenzel, S; Sprung, S; Lax, SF; Marth, C; Fiegl, H; Zeimet, AG BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Br J Cancer. 2018; 119(6):683-692 Doi: 10.1038/s41416-018-0217-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Abbasi, MR; Rifatbegovic, F; Brunner, C; Mann, G; Ziegler, A; Pötschger, U; Crazzolara, R; Ussowicz, M; Benesch, M; Ebetsberger-Dachs, G; Chan, GCF; Jones, N; Ladenstein, R; Ambros, IM; Ambros, PF Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
Clin Cancer Res. 2017; 23(15):4224-4232 Doi: 10.1158/1078-0432.CCR-16-2082 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Betge, J; Harbaum, L; Pollheimer, MJ; Lindtner, RA; Kornprat, P; Ebert, MP; Langner, C Lymph node retrieval in colorectal cancer: determining factors and prognostic significance.
Int J Colorectal Dis. 2017; 32(7):991-998 Doi: 10.1007/s00384-017-2778-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cuppens, T; Annibali, D; Coosemans, A; Trovik, J; Ter Haar, N; Colas, E; Garcia-Jimenez, A; Van de Vijver, K; Kruitwagen, RP; Brinkhuis, M; Zikan, M; Dundr, P; Huvila, J; Carpén, O; Haybaeck, J; Moinfar, F; Salvesen, HB; Stukan, M; Mestdagh, C; Zweemer, RP; Massuger, LF; Mallmann, MR; Wardelmann, E; Mints, M; Verbist, G; Thomas, D; Gommé, E; Hermans, E; Moerman, P; Bosse, T; Amant, F Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
Clin Cancer Res. 2017; 23(5):1274-1285 Doi: 10.1158/1078-0432.CCR-16-2149 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Czapiewski, P; Bobowicz, M; Pęksa, R; Skrzypski, M; Gorczyński, A; Szczepańska-Michalska, K; Korwat, A; Jankowski, M; Zegarski, W; Szulgo-Paczkowska, A; Polec, T; Piątek, M; Skokowski, J; Haybaeck, J; Żaczek, A; Biernat, W Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
Pol J Pathol. 2017; 67(3):228-234 Doi: 10.5114/pjp.2016.63774 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386 Doi: 10.1158/0008-5472.CAN-16-2320 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Drechsler, C; Hayek, SS; Wei, C; Sever, S; Genser, B; Krane, V; Meinitzer, A; März, W; Wanner, C; Reiser, J Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Clin J Am Soc Nephrol. 2017; 12(8):1265-1273 Doi: 10.2215/CJN.10881016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 Doi: 10.1158/1078-0432.CCR-16-0919 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Haymerle, G; Kadletz, L; Wiebringhaus, R; Golabi, B; Mildner, M; Thurnher, D; Heiduschka, G ELMO3 predicts poor outcome in T1 laryngeal cancer.
Clin Otolaryngol. 2017; 42(6):1181-1186 Doi: 10.1111/coa.12845
Web of Science PubMed FullText FullText_MUG

 

Jeryczynski, G; Thiele, J; Gisslinger, B; Wölfler, A; Schalling, M; Gleiß, A; Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Schlögl, E; Geissler, K; Krauth, MT; Nader, A; Vesely, M; Simonitsch-Klupp, I; Müllauer, L; Beham-Schmid, C; Gisslinger, H Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.
Am J Hematol. 2017; 92(9):885-891 Doi: 10.1002/ajh.24788 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lill, C; Bachtiary, B; Selzer, E; Mittlboeck, M; Thurnher, D A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.
Wien Klin Wochenschr. 2017; 129(11-12):398-403 Doi: 10.1007/s00508-017-1171-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 Doi: 10.1016/j.ejca.2016.12.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mynarek, M; Pizer, B; Dufour, C; van Vuurden, D; Garami, M; Massimino, M; Fangusaro, J; Davidson, T; Gil-da-Costa, MJ; Sterba, J; Benesch, M; Gerber, N; Juhnke, BO; Kwiecien, R; Pietsch, T; Kool, M; Clifford, S; Ellison, DW; Giangaspero, F; Wesseling, P; Gilles, F; Gottardo, N; Finlay, JL; Rutkowski, S; von Hoff, K Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.
Neuro Oncol. 2017; 19(4):576-585 Doi: 10.1093/neuonc/now234 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nass, N; Walter, S; Jechorek, D; Weissenborn, C; Ignatov, A; Haybaeck, J; Sel, S; Kalinski, T High neuronatin (NNAT) expression is associated with poor outcome in breast cancer.
Virchows Arch. 2017; 471(1): 23-30. Doi: 10.1007/s00428-017-2154-7
Web of Science PubMed FullText FullText_MUG

 

Panzuto, F; Merola, E; Pavel, ME; Rinke, A; Kump, P; Partelli, S; Rinzivillo, M; Rodriguez-Laval, V; Pape, UF; Lipp, R; Gress, T; Wiedenmann, B; Falconi, M; Delle Fave, G Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
Oncologist. 2017; 22(4):409-415 Doi: 10.1634/theoncologist.2016-0351 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Planells-Palop, V; Hazazi, A; Feichtinger, J; Jezkova, J; Thallinger, G; Alsiwiehri, NO; Almutairi, M; Parry, L; Wakeman, JA; McFarlane, RJ Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.
Mol Cancer. 2017; 16(1): 84-84. Doi: 10.1186/s12943-017-0653-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reismüller, B; Steiner, M; Pichler, H; Dworzak, M; Urban, C; Meister, B; Schmitt, K; Pötschger, U; König, M; Mann, G; Haas, OA; Attarbaschi, A; Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
Pediatr Blood Cancer. 2017; 64(6): Doi: 10.1002/pbc.26327
Web of Science PubMed FullText FullText_MUG

 

Roberts, KJ; Schrem, H; Hodson, J; Angelico, R; Dasari, BVM; Coldham, CA; Marudanayagam, R; Sutcliffe, RP; Muiesan, P; Isaac, J; Mirza, DF Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
HPB (Oxford). 2017; 19(10): 859-867. Doi: 10.1016/j.hpb.2017.05.009 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robin, M; Porcher, R; Zinke-Cerwenka, W; van Biezen, A; Volin, L; Mufti, G; Craddock, C; Finke, J; Richard, C; Passweg, J; Peniket, A; Maertens, J; Sucak, G; Gedde-Dahl, T; Vitek, A; Nagler, A; Blaise, D; Beelen, D; Maillard, N; Schwerdtfeger, R; de Witte, T; Kroger, N Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT.
Bone Marrow Transplant. 2017; 52(2):209-215 Doi: 10.1038/bmt.2016.266 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Singer, CF; Tan, YY; Fitzal, F; Steger, GG; Egle, D; Reiner, A; Rudas, M; Moinfar, F; Gruber, C; Petru, E; Bartsch, R; Tendl, KA; Fuchs, D; Seifert, M; Exner, R; Balic, M; Bago-Horvath, Z; Filipits, M; Gnant, M; Austrian Breast and Colorectal Cancer Study Group Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.
Clin Cancer Res. 2017; 23(14):3676-3683 Doi: 10.1158/1078-0432.CCR-16-2373 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Babjuk, M; Burger, M; Compérat, E; Gontero, P; Lam, T; MacLennan, S; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Eur Urol. 2017; 72(5):801-813 Doi: 10.1016/j.eururo.2017.04.015
Web of Science PubMed FullText FullText_MUG

 

Stiegelbauer, V; Vychytilova-Faltejskova, P; Karbiener, M; Pehserl, AM; Reicher, A; Resel, M; Heitzer, E; Ivan, C; Bullock, M; Ling, H; Deutsch, A; Wulf-Goldenberg, A; Adiprasito, JB; Stoeger, H; Haybaeck, J; Svoboda, M; Stotz, M; Hoefler, G; Slaby, O; Calin, GA; Gerger, A; Pichler, M miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
Clin Cancer Res. 2017; 23(17):5255-5266 Doi: 10.1158/1078-0432.CCR-17-0023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Bonin, S; Donada, M; Bussolati, G; Nardon, E; Annaratone, L; Pichler, M; Chiaravalli, AM; Capella, C; Hoefler, G; Stanta, G A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.
Tumour Biol. 2016; 37(6):7295-7303 Doi: 10.1007/s13277-015-4543-3
Web of Science PubMed FullText FullText_MUG

 

Eigentler, TK; Gutzmer, R; Hauschild, A; Heinzerling, L; Schadendorf, D; Nashan, D; Hölzle, E; Kiecker, F; Becker, J; Sunderkötter, C; Moll, I; Richtig, E; Pönitzsch, I; Pehamberger, H; Kaufmann, R; Pföhler, C; Vogt, T; Berking, C; Praxmarer, M; Garbe, C; Dermatologic Cooperative Oncology Group (DeCOG) Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.
Ann Oncol. 2016; 27(8):1625-1632 Doi: 10.1093/annonc/mdw225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gakis, G; Morgan, TM; Efstathiou, JA; Keegan, KA; Mischinger, J; Todenhoefer, T; Schubert, T; Zaid, HB; Hrbacek, J; Ali-El-Dein, B; Clayman, RH; Galland, S; Olugbade, K; Rink, M; Fritsche, HM; Burger, M; Chang, SS; Babjuk, M; Thalmann, GN; Stenzl, A; Daneshmand, S Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.
World J Urol. 2016; 34(1):97-103 Doi: 10.1007/s00345-015-1583-7
Web of Science PubMed FullText FullText_MUG

 

Harada, Y; Izumi, H; Noguchi, H; Kuma, A; Kawatsu, Y; Kimura, T; Kitada, S; Uramoto, H; Wang, KY; Sasaguri, Y; Hijioka, H; Miyawaki, A; Oya, R; Nakayama, T; Kohno, K; Yamada, S Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Tumour Biol. 2016; 37(1):1357-1368 Doi: 10.1007/s13277-015-3928-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776 Doi: 10.21873/anticanres.11034 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hügel, R; Muendlein, A; Volbeding, L; Drexel, H; Richtig, E; Wehkamp, U; Painsi, C; Lange-Asschenfeldt, B; Hauschild, A; Egberts, F Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
Melanoma Res. 2016; 26(4):354-360 Doi: 10.1097/CMR.0000000000000269
Web of Science PubMed FullText FullText_MUG

 

Jueckstock, J; Rack, B; Friedl, TW; Scholz, C; Steidl, J; Trapp, E; Tesch, H; Forstbauer, H; Lorenz, R; Rezai, M; Häberle, L; Alunni-Fabbroni, M; Schneeweiss, A; Beckmann, MW; Lichtenegger, W; Fasching, PA; Pantel, K; Janni, W; SUCCESS Study Group Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
BMC Cancer. 2016; 16(10):401-401 Doi: 10.1186/s12885-016-2454-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906 Doi: 10.1016/j.ejso.2016.03.026
Web of Science PubMed FullText FullText_MUG

 

Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 Doi: 10.1007/s13277-015-3805-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mir, O; Brodowicz, T; Italiano, A; Wallet, J; Blay, JY; Bertucci, F; Chevreau, C; Piperno-Neumann, S; Bompas, E; Salas, S; Perrin, C; Delcambre, C; Liegl-Atzwanger, B; Toulmonde, M; Dumont, S; Ray-Coquard, I; Clisant, S; Taieb, S; Guillemet, C; Rios, M; Collard, O; Bozec, L; Cupissol, D; Saada-Bouzid, E; Lemaignan, C; Eisterer, W; Isambert, N; Chaigneau, L; Cesne, AL; Penel, N Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol. 2016; 17(12):1732-1742 Doi: 10.1016/S1470-2045(16)30507-1
Web of Science PubMed FullText FullText_MUG

 

Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272 Doi: 10.1038/bjc.2016.325 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Resch, A; Harbaum, L; Pollheimer, MJ; Kornprat, P; Lindtner, RA; Langner, C Inclusion of cytological features in tumor grading improves prognostic stratification of patients with colorectal cancer.
Int J Colorectal Dis. 2016; 31(3):535-541 Doi: 10.1007/s00384-015-2495-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281 Doi: 10.1007/s00404-015-3879-7
Web of Science PubMed FullText FullText_MUG

 

Schrem, H; Schneider, V; Kurok, M; Goldis, A; Dreier, M; Kaltenborn, A; Gwinner, W; Barthold, M; Liebeneiner, J; Winny, M; Klempnauer, J; Kleine, M Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
PLoS One. 2016; 11(7): e0158732-e0158732. Doi: 10.1371/journal.pone.0158732 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwameis, R; Grimm, C; Brodowicz, T; Petru, E; Hefler-Frischmuth, K; Staudigl, C; Reinthaller, A; Heinze, G; Polterauer, S; Polterauer, M Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Sci Rep. 2016; 6(5):33757-33757 Doi: 10.1038/srep33757 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, LC; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, AK; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).
Ann Oncol. 2016; 27(12):2236-2241 Doi: 10.1093/annonc/mdw418 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
Wien Klin Wochenschr. 2016; 128(9-10):320-328 Doi: 10.1007/s00508-016-0963-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Te Grootenhuis, NC; van der Zee, AG; van Doorn, HC; van der Velden, J; Vergote, I; Zanagnolo, V; Baldwin, PJ; Gaarenstroom, KN; van Dorst, EB; Trum, JW; Slangen, BF; Runnebaum, IB; Tamussino, K; Hermans, RH; Provencher, DM; de Bock, GH; de Hullu, JA; Oonk, MH Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I.
Gynecol Oncol. 2016; 140(1):8-14 Doi: 10.1016/j.ygyno.2015.09.077
Web of Science PubMed FullText FullText_MUG

 

Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330 Doi: 10.1136/jclinpath-2015-203356
Web of Science PubMed FullText FullText_MUG

 

Weber, ML; Schneider, DT; Offenmüller, S; Kaatsch, P; Einsiedel, HG; Benesch, M; Claviez, A; Ebinger, M; Kramm, C; Kratz, C; Lawlor, J; Leuschner, I; Merkel, S; Metzler, M; Nustede, R; Petsch, S; Seeger, KH; Schlegel, PG; Suttorp, M; Zolk, O; Brecht, IB Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.
Pediatr Blood Cancer. 2016; 63(4):611-617 Doi: 10.1002/pbc.25839
Web of Science PubMed FullText FullText_MUG

 

2015

Benhaim, L; Zhang, W; Wakatsuki, T; Yang, D; Gerger, A; Bohanes, P; Paez, D; Loupakis, F; LaBonte, MJ; Ning, Y; El-Khoueiry, R; Ladner, R; Wilson, P; Zhang, H; Giamas, G; Stebbing, J; Lenz, HJ Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.
Pharmacogenomics J. 2015; 15(3):235-240 Doi: 10.1038/tpj.2014.58
Web of Science PubMed FullText FullText_MUG

 

Bollen, L; Wibmer, C; Wang, M; van der Linden, YM; Leithner, A; Bünger, CE; Jensen, AB; Fiocco, M; Bratschitsch, G; Pondaag, W; Bovée, JV; Dijkstra, PD Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
Clin Exp Metastasis. 2015; 32(1):1-5 Doi: 10.1007/s10585-014-9685-y
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum